The Russian Direct Investment Fund on Monday announced an agreement with the Indian Panacea Biotec to produce 100 million annual doses of the Sputnik V coronavirus vaccine.

The deal would allow RDIF to provide its international partners with the jab, the Russian sovereign fund said in a statement. EFE-EPA